Efficacy and safety of chimeric antigen receptor T cell therapy in relapsed/refractory diffuse large B-cell lymphoma with different HBV status: a retrospective study from a single...

por Kong, Danqing, Ping, Nana, Gao, Xin, Zou, Rui, Wang, Peng, Wu, Depei, Jin, Zhengming, Qu, Changju
Publicado 2023

Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag

por Tang, Cen, Chen, Feng, Kong, Danqing, Ma, Qinfen, Dai, Haiping, Yin, Jia, Li, Zheng, Chen, Jia, Zhu, Xiaming, Mao, Xinliang, Wu, Depei, Tang, Xiaowen
Publicado 2018

Decitabine-primed tandem CD19/CD22 CAR-T therapy in relapsed/refractory diffuse large B-cell lymphoma patients

por Qu, Changju, Zou, Rui, Wang, Peng, Zhu, Qian, Kang, Liqing, Ping, Nana, Xia, Fan, Liu, Hailing, Kong, Danqing, Yu, Lei, Wu, Depei, Jin, Zhengming
Publicado 2022

P1089: ZANUBRUTINIB-RITUXIMAB CHEMO-FREE THERAPY WITH OR WITHOUT AUTOLOGOUS STEM CELL TRANSPLANTATION IN NEWLY DIAGNOSED MANTLE CELL LYMPHOMA

por Qu, Chang-Ju, Zou, Rui, He, Jia-Jie, Ping, Na-Na, Zhu, Qian, Zhang, Xiao, Xia, Fan, Kong, Danqing, Wu, De-Pei, Jin, Zheng-Ming
Publicado 2023